WHARTEXA 12B HUC-MSCs Exosome
Whartexa 12B HUC-MSCs Exosome is an advanced regenerative extracellular vesicle formulation developed by Nanoventra under the proprietary Whartexa Line.
​
Derived from carefully processed Wharton’s Jelly Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs), this high-purity exosome system is engineered through precision isolation, purification, and cryopreservation technologies intended to support extracellular vesicle integrity, biological consistency, and advanced regenerative signaling functionality.
Human-Derived Exosomes From:*
Wharton’s Jelly
Product image shown represents the finalized Whartexa formulation. Actual presentation may vary slightly depending on packaging updates, preservation configuration, and production optimization protocols.
Details
Quality
Related Products
Details
WHARTEXA 12B HUC-MSCs Exosome
Nanoventra provides advanced HUC-MSC-derived extracellular vesicle systems developed through controlled isolation, purification, and cryopreservation methodologies intended to preserve vesicle stability, extracellular integrity, and biological signaling consistency.
​
Whartexa 12B is formulated from carefully processed Wharton’s Jelly umbilical biological sources and represents an enhanced concentration variant within the proprietary Whartexa regenerative platform.
This formulation is optimized for professional regenerative integration environments requiring elevated extracellular vesicle concentration support, laboratory-grade handling consistency, and advanced nano-vesicle preparation methodologies.
​
Human umbilical cord-derived extracellular vesicles are increasingly recognized for their regenerative signaling relevance and their growing role within regenerative biotechnology, aesthetic science, dermatological integration systems, and advanced cellular communication research.
Key Features
-
Proprietary Whartexa regenerative exosome platform
-
Human Wharton’s Jelly HUC-MSC-derived extracellular vesicles
-
12 Billion particle concentration system
-
Enhanced extracellular vesicle concentration support
-
Advanced purification and vesicle isolation workflows
-
Controlled laboratory-grade preparation methodologies
-
Cryopreserved formulation maintained at −20°C
-
Optimized biological consistency and vesicle stability
-
Professional regenerative and biotechnology-oriented integration
-
Advanced extracellular nano-vesicle preservation protocols
-
Research-focused exosome preparation standards
Quality
Specifications
All Whartexa 12B HUC-MSCs Exosome formulations undergo advanced scientific quality verification through multi-stage extracellular vesicle processing, laboratory-oriented handling systems, and controlled purification methodologies.
​
Each preparation is processed under sterile laboratory-grade conditions with focused attention toward:
-
extracellular vesicle integrity
-
particle consistency
-
biological stability
-
purification precision
-
advanced processing reproducibility
-
​
Nanoventra applies biotechnology-oriented quality methodologies intended to support consistency across regenerative extracellular vesicle systems and advanced exosome preparation workflows.
The Whartexa Line represents Nanoventra’s premium regenerative exosome division developed for advanced extracellular vesicle refinement and biotechnology-grade formulation engineering.
Storage & Handling
-
Recommended storage temperature: −20°C
-
Maintain cryopreserved conditions during handling
-
Avoid repeated freeze-thaw exposure
-
Professional laboratory-oriented handling recommended